Klein Matthew B. sold PTCT
February 18, 2026 · Form 4 insider transaction
Klein Matthew B. sold 7,371 shares of PTC Therapeutics, Inc. at $69.36 per share, a transaction worth $511.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,371
Price
$69.36
Total value
$511.3K
InsiderKlein Matthew B.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 18, 2026
Filing dateFebruary 20, 2026
Shares owned after387,082
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 17,500 RSUs from a February 15, 2025 grant of 70,000 RSUs.